Yangtze River Pharmaceutical(Group) Co.,

Yangtze River Pharmaceutical(Group) Co.,

About

Company description

Yangtze River Pharmaceutical Group (hereinafter referred to as YRPG) is a Chinese large-scale cross-region pharmaceutical group founded in 1971. Till July 2019, with a total area of over 3 million square meters, YRPG owns 14 manufacturing subsidiaries located in Beijing, Shanghai, Nanjing, Guangzhou etc. and has established R&D and production bases of innovative chemical medicine, patent traditional Chinese medicine (TCMs) and biological medicines. 
4 workshops, 6 FDFs and 1 NEX had been EU GMP certified (Enalapril Maleate Tablets, Omeprazole Enteric-coated Capsules, Nifedipine Prolonged Release Tablets, Glimepiride Tablets, Sotalol Hydrochloride Tablets, Gingko Biloba Tablets and Gingko Biloba Extract). Omeprazole Capsules was exported to Germany in 2012. 79 FDFs have been exported to 25 countries/areas in Europe, Asia and Africa. From 2012 to 2018, YRPG was awarded Top 1 among Top 100 Enterprises in China Chemical Pharmaceutical Industry.
From 2014 to 2018, YRPG was awarded Top 1 among Top 100 Enterprises in China Pharmaceutical Industry.
In 2016, YRPG was honored Global Performance Excellence Award (World Class).
In 2016 and 2018, YRPG was honored Nomination of China Quality Award.
In 2016 and 2019, YRPG was honored Top 1 among China Brand Evaluation of Bio-pharmaceutical Field (both brand power and brand value).

Quick facts

Sales markets Eastern Europe; Middle East; Asia; North America; Africa; Central/South America
Affiliated categories: Antibiotics |Antineoplastic / Chemotherapeutic agent / Anthracyclines |API Contract Manufacturing More

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 90C50 See our Exhibitor Profile   See full Exhibitor List
16 sep 2019

CPHI Middle East & Africa 2019

16 -18 September 2019 ADNEC, Abu Dhabi, UAE We were at stand H63 See our Exhibitor Profile   See full Exhibitor List
12 mar 2019

CPhI South East Asia 2019

12-14 March 2019 Bangkok, Thailand We were at stand LB44 See our Exhibitor Profile   See full Exhibitor List

Our Top products

Esomeprazole Sodium for Injection

Esomeprazole Sodium for Injection

DIGESTIVE SYSTEM AGENTS

More info
Pantoprazole Sodium for Injection

Pantoprazole Sodium for Injection

DIGESTIVE SYSTEM AGENTS

More info
Parecoxib Sodium for Injection

Parecoxib Sodium for Injection

ANALGESIC AGENTS

More info
View all our products (73)

News about Yangtze River Pharmaceutical(Group) Co.,

Yangtze River Pharmaceutical Group achieved Double Winners of 2019 China Brand Evaluation

22 Jul 2019

Yangtze River Pharmaceutical Group achieved Double Winners of 2019 China Brand Evaluation

Yangtze River Pharmaceutical Group achieved the double winners in China pharmaceutical field with Brand Value of RMB 42.869 billion and Brand Strength of 980 points, and became veritable No.1 brand in China pharmaceutical industry.

Read more
Yangtze River Pharmaceutical(Group) Co.,

Contact information

Address

Telephone

Website

View all contact information